Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
0.42Price to Sales
VS
Market
Sector
Industry
History
$ 0.54Close
$ 0.39 - $ 1.72 52-Week Range
Ticker Information
Ticker
IPSCCompany Name
CENTURY THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCENTURY THERAPEUTICS INC - Price to Sales Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
IPSC - P/S Historical data
| Date | Market Capitalization | Price to Sales | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 47.51M | 0.42 | $ 114.13M |
| 3/31/2025 | $ 44.54M | 0.39 | $ 114.9M |
| 12/31/2024 | $ 50.16M | 7.61 | $ 6.59M |
| 9/30/2024 | $ 113.09M | 42.12 | $ 2.69M |
| 6/30/2024 | $ 152.49M | 74.68 | $ 2.04M |
| 3/31/2024 | $ 251.86M | 183.84 | $ 1.37M |
| 12/31/2023 | $ 292.33M | 130.8 | $ 2.23M |
| 9/30/2023 | $ 83.17M | 33.43 | $ 2.49M |
| 6/30/2023 | $ 170.33M | 37.32 | $ 4.56M |
| 3/31/2023 | $ 200.79M | 34.26 | $ 5.86M |
Key Performance Insights, Last 5 Years
- CENTURY THERAPEUTICS INC's latest trailing twelve months (TTM) P/S stands at 0.
- Over the past 5 years, CENTURY THERAPEUTICS INC's average P/S has been 106.89.
- The median P/S for CENTURY THERAPEUTICS INC during this period was 43.71
- CENTURY THERAPEUTICS INC reached its highest P/S over the past 5 years at 492.83.
- The lowest P/S recorded by CENTURY THERAPEUTICS INC in the same timeframe 0.39
CENTURY THERAPEUTICS INC's P/S vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/S Benchmarks
Similar metrics to Revenues:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Book - [Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
Definition of Price to Sales
[Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].Market Cap / Revenues
(=) P/S P/S for CENTURY THERAPEUTICS INC is calculated as follows: Market Cap [ $ 0 ] / Revenues [ $ 0 ]
(=) P/S [ 0 ] IPSC - Price to Sales, Last 5 years
0.39
Minimum
Mar 31, 2025
492.83
Maximum
Mar 31, 2022
106.89
Average
43.71
Median
P/S Benchmark AnalysisMarket
The chart above depicts the distribution of P/S for companies in the Total Stock Market. The average P/S of the companies is 2.62 with a standard deviation of 2.38.
The following table provides additional summary stats:
P/S in the Market:
| filtered constituents | 3.42K |
|---|---|
| min | 0 |
| max | 11.15 |
| average | 2.62 |
| median | 1.97 |
| std | 2.38 |